There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The combination treatment reduced the need for ...

Treatment with the antiviral remdesivir (Veklury) plus dexamethasone was linked to fewer deaths among patients hospitalized for COVID-19 compared with dexamethasone monotherapy, a retrospective study ...

In late December, as the omicron variant surged, the roster of early COVID-19 treatments was looking slim. Newly authorized pills for COVID-19 were in short supply. Several monoclonal antibody drugs ...

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data ...

Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of a 3-day ...

The US Food and Drug Administration announced Monday that it has expanded approval of the Covid-19 drug remdesivir to treat patients as young as 28 days and weighing about 7 pounds. This is the first ...

Two widows in the Inland Empire are suing Kaiser Permanente and Redlands Community Hospital for using Remdesivir to treat their husbands' COVID-19 diagnoses. "I am a widow and I am 52," said widow ...

This letter was published on February 16, 2022, at NEJM.org. No potential conflict of interest relevant to this letter was reported. Walsh M, Srinathan SK, McAuley DF, et al. The statistical ...